(2R)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide

C210H226Cl2N36O10 — CID 159031354

IUPAC(2R)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide
SMILESCc1ccc(CCN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)c(C)c1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(C3CC3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCN(C)C(=O)C3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ncc(-c3cnn(C)c3)cc2Cl)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)c(C)c1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(C3CC3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCN(C)C(=O)C3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ncc(-c3cnn(C)c3)cc2Cl)c2ccccc2)cc1
InChIInChI=1S/2C27H31N5O2.2C27H29N5O.2C26H26ClN5O.2C25H27N3O/c2*1-20-8-10-21(11-9-20)14-15-28-26(22-6-4-3-5-7-22)27(34)30-23-12-13-24(29-18-23)32-17-16-31(2)25(33)19-32;2*1-19-9-10-21(20(2)15-19)13-14-28-26(22-7-5-4-6-8-22)27(33)31-25-12-11-23(16-29-25)24-17-30-32(3)18-24;2*1-18-8-10-19(11-9-18)12-13-28-24(20-6-4-3-5-7-20)26(33)31-25-23(27)14-21(15-29-25)22-16-30-32(2)17-22;2*1-18-7-9-19(10-8-18)15-16-26-24(21-5-3-2-4-6-21)25(29)28-22-13-14-23(27-17-22)20-11-12-20/h2*3-13,18,26,28H,14-17,19H2,1-2H3,(H,30,34);2*4-12,15-18,26,28H,13-14H2,1-3H3,(H,29,31,33);2*3-11,14-17,24,28H,12-13H2,1-2H3,(H,29,31,33);2*2-10,13-14,17,20,24,26H,11-12,15-16H2,1H3,(H,28,29)/t4*26-;4*24-/m10101010/s1
InChIKeyJUXSLHJFGWDWLW-CBZITQMISA-N
MW3485.27 g/mol
LogP35.05
Rot. Bonds64

About (2R)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide

(2R)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide (PubChem CID 159031354) has the molecular formula C210H226Cl2N36O10 and a molecular weight of 3485.27 g/mol. Its IUPAC name is (2R)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide.

Molecular Properties

Compound Name(2R)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide
PubChem CID159031354
Molecular FormulaC210H226Cl2N36O10
Molecular Weight3485.27 g/mol
Exact Mass3481.77
IUPAC Name(2R)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide
SMILESCc1ccc(CCN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)c(C)c1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(C3CC3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCN(C)C(=O)C3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ncc(-c3cnn(C)c3)cc2Cl)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)c(C)c1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(C3CC3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCN(C)C(=O)C3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ncc(-c3cnn(C)c3)cc2Cl)c2ccccc2)cc1
InChIInChI=1S/2C27H31N5O2.2C27H29N5O.2C26H26ClN5O.2C25H27N3O/c2*1-20-8-10-21(11-9-20)14-15-28-26(22-6-4-3-5-7-22)27(34)30-23-12-13-24(29-18-23)32-17-16-31(2)25(33)19-32;2*1-19-9-10-21(20(2)15-19)13-14-28-26(22-7-5-4-6-8-22)27(33)31-25-12-11-23(16-29-25)24-17-30-32(3)18-24;2*1-18-8-10-19(11-9-18)12-13-28-24(20-6-4-3-5-7-20)26(33)31-25-23(27)14-21(15-29-25)22-16-30-32(2)17-22;2*1-18-7-9-19(10-8-18)15-16-26-24(21-5-3-2-4-6-21)25(29)28-22-13-14-23(27-17-22)20-11-12-20/h2*3-13,18,26,28H,14-17,19H2,1-2H3,(H,30,34);2*4-12,15-18,26,28H,13-14H2,1-3H3,(H,29,31,33);2*3-11,14-17,24,28H,12-13H2,1-2H3,(H,29,31,33);2*2-10,13-14,17,20,24,26H,11-12,15-16H2,1H3,(H,28,29)/t4*26-;4*24-/m10101010/s1
InChIKeyJUXSLHJFGWDWLW-CBZITQMISA-N
XLogP35.05
TPSA550.54 Ų
H-Bond Donors16
H-Bond Acceptors36
Rotatable Bonds64
Heavy Atoms258
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003485.27
LogP ≤ 535.05
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1036

Analyze (2R)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide?
The IUPAC name of (2R)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide (CID 159031354) is (2R)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide.
What is the SMILES notation for (2R)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide?
The canonical SMILES for (2R)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide is Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)c(C)c1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(C3CC3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCN(C)C(=O)C3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ncc(-c3cnn(C)c3)cc2Cl)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)c(C)c1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(C3CC3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCN(C)C(=O)C3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ncc(-c3cnn(C)c3)cc2Cl)c2ccccc2)cc1.
What is the InChIKey of (2R)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide?
The InChIKey is JUXSLHJFGWDWLW-CBZITQMISA-N. The full InChI is InChI=1S/2C27H31N5O2.2C27H29N5O.2C26H26ClN5O.2C25H27N3O/c2*1-20-8-10-21(11-9-20)14-15-28-26(22-6-4-3-5-7-22)27(34)30-23-12-13-24(29-18-23)32-17-16-31(2)25(33)19-32;2*1-19-9-10-21(20(2)15-19)13-14-28-26(22-7-5-4-6-8-22)27(33)31-25-12-11-23(16-29-25)24-17-30-32(3)18-24;2*1-18-8-10-19(11-9-18)12-13-28-24(20-6-4-3-5-7-20)26(33)31-25-23(27)14-21(15-29-25)22-16-30-32(2)17-22;2*1-18-7-9-19(10-8-18)15-16-26-24(21-5-3-2-4-6-21)25(29)28-22-13-14-23(27-17-22)20-11-12-20/h2*3-13,18,26,28H,14-17,19H2,1-2H3,(H,30,34);2*4-12,15-18,26,28H,13-14H2,1-3H3,(H,29,31,33);2*3-11,14-17,24,28H,12-13H2,1-2H3,(H,29,31,33);2*2-10,13-14,17,20,24,26H,11-12,15-16H2,1H3,(H,28,29)/t4*26-;4*24-/m10101010/s1.
What are the key properties of (2R)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide?
(2R)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide has a molecular weight of 3485.27 g/mol, XLogP of 35.05, 64 rotatable bonds, 16 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-chloro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-(6-cyclopropyl-3-pyridinyl)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(2,4-dimethylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[6-(4-methyl-3-oxopiperazin-1-yl)-3-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide is sourced from PubChem (CID 159031354), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).